The Competition and Markets Authority has upheld the former Competition Commission’s decision that requires ferry servicer Eurotunnel to divest its controversial Dover route, say reports.
The Commission, which was combined with the Office of Fair Trading to become the CMA last April, ruled last June that Eurotunnel must divest the route as a consequence of its acquisition of assets following the demise of onetime rival SeaFrance, purchased in 2012. But Eurotunnel appealed the decision, and the Competition Tribunal ordered the Commission to reexamine its decision.
The Tribunal’s order questioned the Commission’s jurisdiction to require divestitures from an entity that is considered an asset or an enterprise.
But the CMA announced this week that Eurotunnel has a majority of the market share of the cross-Channel route, which could lead to higher consumer fees and could lead to the exit of one of its rivals.
Eurotunnel, which runs the route through its MyFerryLink service, could be forced to end the operations by the end of the year; the company, however, has vowed to challenge the CMA’s decision.
Full content: The Guardian
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Athletes File New Objections to NCAA’s $2.8 Billion Settlement Proposal
May 15, 2025 by
CPI
TikTok Charged by EU Over Alleged Breach of Digital Services Act
May 15, 2025 by
CPI
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas